Michel Koole Selected Research

Neoplasms (Cancer)

3/2024	Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging.
9/2022	A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT).
10/2021	Preclinical Evaluation of [11C]YC-72-AB85 for In Vivo Visualization of Heat Shock Protein 90 in Brain and Cancer with Positron Emission Tomography.
1/2021	Synthetic Pept-Ins as a Generic Amyloid-Like Aggregation-Based Platform for In Vivo PET Imaging of Intracellular Targets.
1/2020	Inflammation-Based Index and 68Ga-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC.
12/2017	Pretargeted PET Imaging Using a Bioorthogonal 18F-Labeled trans-Cyclooctene in an Ovarian Carcinoma Model.
12/2015	Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expression.
3/2014	Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
8/2012	Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Koole Research Topics

Disease

10	Neuroinflammatory Diseases 06/2023 - 01/2016
9	Neoplasms (Cancer) 03/2024 - 08/2012
6	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 08/2009
5	Inflammation (Inflammations) 06/2023 - 08/2013
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2013
5	Schizophrenia (Dementia Praecox) 01/2017 - 01/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 01/2020
4	Cognitive Dysfunction 10/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 06/2023 - 08/2021
3	Atrophy 01/2022 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 12/2018
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2020 - 12/2018
2	Ischemic Stroke 01/2023 - 01/2022
2	Huntington Disease (Huntington's Disease) 12/2022 - 01/2013
2	Stroke (Strokes) 01/2022 - 11/2012
2	Central Nervous System Diseases (CNS Diseases) 10/2021 - 01/2014
2	Infections 01/2021 - 01/2018
2	Carcinoma (Carcinomatosis) 12/2017 - 08/2013
2	Myocardial Infarction 01/2015 - 01/2013
2	Amyloidosis 03/2014 - 08/2009
2	Obesity 01/2014 - 03/2008
2	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 08/2012
1	Multiple Myeloma 03/2024
1	Leukemia 03/2024
1	Paraganglioma (Paragangliomas) 01/2023
1	Neuroblastoma 01/2023
1	Glioma (Gliomas) 01/2023
1	Ischemia 01/2023
1	Fatigue 01/2022
1	Chemotherapy-Related Cognitive Impairment 08/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Hemolysis 01/2020
1	Frontotemporal Dementia (Semantic Dementia) 01/2020
1	Hyperoxia 01/2019
1	Primary Progressive Aphasia 12/2018
1	Tauopathies 12/2018
1	Broca Aphasia (Expressive Aphasia) 12/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Hypercapnia 02/2017
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2017

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2009
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2013
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
4	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 08/2021 - 01/2016
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 12/2018
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 03/2024 - 01/2018
3	Amyloid (Amyloid Fibrils)IBA 10/2022 - 01/2018
3	Radioisotopes (Radionuclides)IBA 09/2022 - 12/2017
3	Purinergic P2X7 ReceptorsIBA 01/2020 - 01/2016
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 01/2013
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 01/2023
2	FluorineIBA 01/2021 - 01/2020
2	LipopolysaccharidesIBA 12/2018 - 01/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2015 - 11/2012
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2013 - 11/2012
2	Choline (Choline Chloride)IBA 04/2013 - 08/2012
2	EndocannabinoidsIBA 11/2012 - 03/2008
1	CXC ChemokinesIBA 03/2024
1	68Ga-pentixaforIBA 03/2024
1	plerixafor FDA Link 03/2024
1	Octreotide (Sandostatin)FDA LinkGeneric 06/2023
1	tau Proteins (tau Protein)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2023
1	Muscarinic M4 ReceptorIBA 12/2022
1	RadiopharmaceuticalsIBA 09/2022
1	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2021
1	1,10- phenanthroline- platinum(II)- ethylenediamine (PEPT)IBA 01/2021
1	Polyvinyl Chloride (PVC)IBA 01/2021
1	MK-6240IBA 01/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020
1	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2020
1	Ga(III)-DOTATOCIBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 09/2019
1	Ion Channels (Ion Channel)IBA 09/2019
1	CannabinoidsIBA 01/2019
1	alpha-SynucleinIBA 01/2019
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	THK5351IBA 12/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2018
1	Antimicrobial PeptidesIBA 01/2018
1	ribosomal protein S30IBA 01/2018
1	Peroxisomal Multifunctional Protein-2IBA 01/2018
1	AntibodiesIBA 12/2017
1	Trastuzumab (Herceptin)FDA Link 12/2017
1	Fluorine-18IBA 12/2017
1	Urethane (Ethyl Carbamate)IBA 02/2017
1	ChloraloseIBA 02/2017
1	metabotropic glutamate receptor 2IBA 01/2017

Therapy/Procedure

5	Therapeutics 09/2022 - 04/2013
3	Drug Therapy (Chemotherapy) 06/2023 - 08/2021
2	Injections 01/2019 - 08/2014
1	Neoadjuvant Therapy 01/2022
1	Anesthesia 02/2017